Akamai Technologies, Inc. (0HBQ.L)
| Previous close | 101.95 |
| Open | 91.73 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 91.24 - 94.83 |
| 52-week range | 71.55 - 129.17 |
| Volume | |
| Avg. volume | 1,813 |
| Market cap | 147.35M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 0.25 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Akamai Technologies, Inc. (NASDAQ:AKAM) Q1 2024 Earnings Call Transcript
Akamai Technologies, Inc. (NASDAQ:AKAM) Q1 2024 Earnings Call Transcript May 9, 2024 Akamai Technologies, Inc. misses on earnings expectations. Reported EPS is $1.11 EPS, expectations were $1.61. Akamai Technologies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day […]
- Barrons.com
These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More
Novavax stock surged after the vaccine maker signs a $1.2 billion licensing deal with France’s Sanofi, guidance from Akamai Technologies missed estimates, and Sweetgreen soared after the salad chain boosts its full-year revenue outlook.
- StockStory
Why Akamai (AKAM) Shares Are Sliding Today
Shares of web content delivery and security company Akamai (NASDAQ:AKAM) fell 11.2% in the morning session after the company reported first-quarter earnings results. Although its EPS beat Wall Street's estimates, its full-year revenue guidance missed analysts' expectations, sending the stock down. Company outlooks have been the big focus this earnings season. On the bright side, the Board authorized a new three-year, $2.0 billion share repurchase program. Overall, the results could have been bet
